Aveeno Baby®

Unlock the strength of baby’s sensitive skin from within

Only Aveeno Baby® offers a globally recognized portfolio of oat formulations that deliver healing from probiotic cues on newborn skin and effective eczema relief. Aveeno Baby® products are specifically formulated with high‑quality oats to preserve their protective, moisturizing, and soothing properties.

80 years of authority in oat science and babies’ sensitive skin

Aveeno® is the leader in oat science, transforming sensitive skin care with clinically proven, gentle formulations for body and face. Harnessing the science of oat, Aveeno® strengthens the skin barrier and soothes inflammation while delivering trusted, dermatologist-recommended solutions with reliable results.

published studies

clinical tests

babies

newborns

3-way mechanism of action

A unique Aveeno® combination with a multifaceted, three‑way mechanism of action that helps strengthen and soothe the skin from within.

Strengthens the skin barrier

Reduces itching and signs of  inflammation caused by dry skin

Supports the skin microbiome  and normalizes pH

Powered by Triple Oat® Complex

Oat Extract: Soothing

Reduces inflammatory mediators by blocking production of cytokines
Avenanthramides suppress hypersensitivity, inflammation, and itch responses⁷
Oat extract reduces histamine-induced reactive oxidative species in keratinocytes via anti-oxidant properties⁸

Oat Oil: Barrier-Strengthening

Strengthens the skin barrier by stimulating endogenous production of essential elements
Holds moisture within the stratum corneum⁵
Promotes skin's endogenous production of ceramides

Oat Flour: Nourishing

Helps support the skin microbiome by acting as a prebiotic
Oat flour supports the growth of commensal microorganisms like Staphylococcus epidermidis⁷
Oat flour serves as a skin buffer and normalizes pH
Oat flour metabolism increases lactic acid, improving the skin moisture barrier & microbiome diversity in dry/itchy skin and atopic dermatitis^7,9

Oat oil helps stimulate the skin’s endogenous ceramide production up to 3X

Clinical research has found that oat lipids activate PPARβ and induce ceramide formation in skin cells.

Learn more

Supporting the Skin Barrier from Day 1 of Life

Learn how the ideal complex emollient, such as those containing oat, can provide the best health benefits to a newborn.

Aveeno® offers products across different skin profiles

The Aveeno® Baby product lines are designed to cleanse, protect, and help nourish from the first use and are suitable for a variety of skin needs and concerns.

Aveeno Baby® Healthy Start

Safe to use from day 1 of life

Aveeno Baby® Eczema Therapy

Immediate relief with 24 hour moisturization

Aveeno Baby® Daily Moisture

Fortifies the developing skin barrier with 24 hour moisturization

Aveeno Baby® Calming Comfort™ Bedtime®

Helps comfort and soothe before bedtime

Baby Continuous Protection® Broad Spectrum SPF

Provides strong sun protection and helps lock in moisture

Product range guide

	Aveeno® Baby Healthy Start	Aveeno Baby® Eczema Therapy	Aveeno Baby® Daily Moisture	Aveeno Baby® Calming Comfort™	Aveeno Baby® Sun Protection

Skin type	For newborn delicate skin	For sensitive skin with eczema	For sensitive skin everyday care	For sensitive skin's bedtime routine	For sensitive skin continuous protection
Range benefits	Safe for Day 1 use, clinically proven to help moisturize, nourish, and comfort skin in newborn babies	Clinically proven to help moisturize & soothe baby’s dry, itchy skin	Gently helps protect and nourish normal to dry skin	Gently cleanses & moisturizes delicate baby skin, and helps calm baby before bedtime	Provides broad spectrum SPF protection, helps lock in moisture, and nourishes baby skin.
Main ingredients	Triple Oat® Complex Ceramide NP	Triple Oat® Complex Ceramide NP	Natural Oat Extract Prebiotic Colloidal Oatmeal	Prebiotic Colloidal Oatmeal. Lavender and Vanilla scent	Naturally-sourced zinc oxide Oat flour Oat oil
Product formats	Healthy Start Newborn Balm Healthy Start Newborn Wash	Eczema Therapy Nighttime Balm Eczema Therapy Moisturizing Cream Eczema Therapy Soothing Bath Treatment Cleansing Therapy Moisturizing Wash	Hair & body wash Bath & Wash 2-in-1 Shampoo and conditioner Moisturizing lotion Diaper cream	Calming Comfort® Bath Calming Comfort® Lotion	Continuous Protection® Sunscreen Lotion with Broad Spectrum SPF 50 Continuous Protection® Sunscreen Face Stick with Broad Spectrum SPF 50

References

_{1. Data on file. Kenvue Consumer Inc.}

_{2. Lisante TA, Núñez C, Zhang P. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study. J Dermatolog Treat. 2017;28(7):659–667. doi:10.1080/09546634.2017.1303569}

_{3. FDA. Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph. 68 FR 33362. June 4, 2003. Available from: https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm091520.pdf Accessed 8.17.21}

_{4. Health Canada: Medicated Skin Care Products Monograph. http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peu&lang=eng Accessed 8.17.21}

_{5. Ilnytska O, Kaur S, Chon S, et al. Colloidal oatmeal (Avena sativa) improves skin barrier through multi-therapy activity. J Drugs Dermatol. 2016;15(6):684–690.}

_{6. Reynertson KA, Garay M, Nebus J, et al. Anti-inflammatory activities of colloidal oatmeal (Avena sativa) contribute to the effectiveness of oats in treatment of itch associated with dry, irritated skin. J Drugs Dermatol. 2015;14(3):43–48.}

_{7. Liu-Walsh F, Tierney NK, Hauschild J, et al. Prebiotic colloidal oat supports the growth of cutaneous commensal bacteria including S. epidermidis and enhances the production of lactic acid. Clin Cosmet Investig Dermatol. 2021;14:73–82.}

_{8. Chon SH, Tannuhill R, Yao X, Southall MD, Pappas A. Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways. Exp Dermatol. 2015;24(4):290–295.}

_{9. Capone K, et al. J Drugs Dermatol. 2020;19:524–531.}